Even though the relevance of ANXA3 phosphorylation/dysregulation has not yet been determined, these results suggest a potential impact on NPC treatment, and encourage deepening on ANXA3 contribution in HNC since it could positively impact patient management and disease outcome. The gene discussed is ANXA3; the disease is nasopharyngeal carcinoma.